标普和纳斯达克内在价值 联系我们
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 返回所有股票

Aravive, Inc. ARAV NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.25
+523.4%

共有 50 笔近期内部人交易记录记录，涉及 Aravive, Inc. (ARAV), 包括 43 笔买入 和 1 笔卖出. 内部人买入总额为 $17.14M 内部人卖出总额为 $9.3K.

近期活跃的重要内部人包括 Petrini Maria Carolina, Howard Rudy, Mcintyre Gail Frances. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — ARAV

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2023-04-10 Petrini Maria Carolina Officer 未知 - - - -
2023-04-10 Petrini Maria Carolina Chief Commercial Officer 限制性股票授予 (RSU) 400,000 $1.86 $744K 400,000
2023-02-01 Howard Rudy Chief Financial Officer 限制性股票授予 (RSU) 400,000 $1.67 $668K 400,000
2023-02-01 Mcintyre Gail Frances CEO and President 限制性股票授予 (RSU) 700,000 $1.67 $1.17M 700,000
2023-02-01 Dove Leonard Scott Chief Operating Officer 限制性股票授予 (RSU) 400,000 $1.67 $668K 400,000
2023-02-01 Geller Robert B. Chief Medical Officer 限制性股票授予 (RSU) 400,000 $1.67 $668K 400,000
2022-10-24 Eshelman Fredric N 10 Percent Owner, Officer: Executive Chairman 限制性股票授予 (RSU) 8,153,060 $0.79 $6.48M 8,153,060
2022-10-24 Howard Rudy Chief Financial Officer 限制性股票授予 (RSU) 5,435 - - 5,435
2022-10-24 Mcintyre Gail Frances CEO and President 限制性股票授予 (RSU) 27,176 - - 27,176
2022-10-24 Ho Peter Tai-ching Director 限制性股票授予 (RSU) 27,176 - - 27,176
2022-10-24 Giaccia Amato Director 限制性股票授予 (RSU) 135,884 - - 135,884
2022-10-24 Zhang Eric Director 限制性股票授予 (RSU) 271,768 - - 271,768
2022-10-24 Ho Peter Tai-ching Director 限制性股票授予 (RSU) 27,176 - - 27,176
2022-10-24 Zhang Eric Director 限制性股票授予 (RSU) 271,768 - - 271,768
2022-09-23 Eshelman Fredric N 10 Percent Owner, Officer: Executive Chairman 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-09-23 Rogers Michael W Director 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-09-23 Kirk Sigurd Director 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-09-23 Ho Peter Tai-ching Director 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-09-23 Hohneker John Director 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-09-23 Giaccia Amato Director 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-09-23 Zhang Eric Director 限制性股票授予 (RSU) 97,063 $0.92 $88.83K 97,063
2022-07-01 Geller Robert B. Officer 未知 - - - -
2022-07-01 Geller Robert B. Chief Medical Officer 限制性股票授予 (RSU) 200,000 - - 200,000
2022-06-03 Howard Rudy Officer 未知 - - - -
2022-06-03 Howard Rudy Chief Financial Officer 限制性股票授予 (RSU) 290,000 - - 290,000
2022-04-01 Eshelman Fredric N 10 Percent Owner, Officer: Executive Chairman of Board 期权行权 4,545,455 $0.00 $454.55 -
2022-04-01 Eshelman Ventures, Llc Director 期权行权 4,545,455 - - -
2022-03-29 Eshelman Fredric N 10 Percent Owner, Officer: Executive Chairman of Board 限制性股票授予 (RSU) 860,216 $2.20 $1.89M 860,216
2022-03-29 Eshelman Ventures, Llc Director 限制性股票授予 (RSU) 860,216 $2.20 $1.89M 860,216
2022-03-21 Dove Leonard Scott Officer 未知 - - - -
2022-03-21 Dove Leonard Scott Chief Operating Officer 限制性股票授予 (RSU) 200,000 - - 200,000
2022-01-24 Mcintyre Gail Frances CEO and President 限制性股票授予 (RSU) 425,000 $2.18 $926.5K 425,000
2022-01-24 Shah Vinay Chief Financial Officer 限制性股票授予 (RSU) 175,000 $2.18 $381.5K 175,000
2022-01-24 Rangwala Reshma Chief Medical Officer 限制性股票授予 (RSU) 175,000 $2.18 $381.5K 175,000
2022-01-03 Eshelman Fredric N 10 Percent Owner, Officer: Executive Chairman of Board 限制性股票授予 (RSU) 4,545,455 $0.00 $454.55 4,545,455
2021-12-03 Giaccia Amato Director 赠与（送出） 48,366 - - 941,880
2021-11-30 Giaccia Amato Director 期权行权（卖出） 38,761 $0.24 $9.3K -
2021-09-10 Eshelman Fredric N 10 Percent Owner 限制性股票授予 (RSU) 22,812 $3.97 $90.56K 22,812
2021-09-10 Rogers Michael W Director 限制性股票授予 (RSU) 22,812 $3.97 $90.56K 22,812
2021-09-10 Kirk Sigurd Director 限制性股票授予 (RSU) 22,812 - - 22,812
2021-09-10 Ho Peter Tai-ching Director 限制性股票授予 (RSU) 22,812 $3.97 $90.56K 22,812
2021-09-10 Hohneker John Director 限制性股票授予 (RSU) 22,812 $3.97 $90.56K 22,812
2021-09-10 Giaccia Amato Director 限制性股票授予 (RSU) 22,812 $3.97 $90.56K 22,812
2021-09-10 Zhang Eric Director 限制性股票授予 (RSU) 22,812 $3.97 $90.56K 22,812
2021-07-01 Kirk Sigurd Director 限制性股票授予 (RSU) 5,245 $5.80 $30.42K 5,245
2021-07-01 Ho Peter Tai-ching Director 限制性股票授予 (RSU) 5,245 $5.80 $30.42K 5,245
2021-07-01 Hohneker John Director 限制性股票授予 (RSU) 5,245 $5.80 $30.42K 5,245
2021-06-29 Mcintyre Gail Frances CEO and President 知情买入 1,000 $5.35 $5.35K 11,137
2021-06-29 Shah Vinay Chief Financial Officer 知情买入 1,000 $5.31 $5.31K 190,842
2021-05-12 Kirk Sigurd Director 未知 - - - -
■ 知情交易 — 公开市场买卖（最具参考价值） ■ 非知情买入 — 奖励、期权行权、转换 ■ 非知情卖出 — 税务代扣、归属出售 ■ 中性 — 礼赠、信托、到期

其他人也在看

ASLN
ASLN
ASLAN Pharmaceuticals Limited
$0.60
-14.27%
 AUTL
AUTL
Autolus Therapeutics plc
$1.50
+2.04%
 AGLE
AGLE
Aeglea BioTherapeutics, Inc.
$12.01
+6.66%
 MGTA
MGTA
Magenta Therapeutics, Inc.
$0.70
-7.74%
 AVRO
AVRO
AVROBIO, Inc.
$1.40
-1.41%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值，发现被低估的股票。
每周在线课程
📧 [email protected]
📞 +65 8912 8000
给我们留言